Internal ribosome entry site-based vectors for combined gene therapy
about
Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models.Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.
P2860
Internal ribosome entry site-based vectors for combined gene therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Internal ribosome entry site-based vectors for combined gene therapy
@ast
Internal ribosome entry site-based vectors for combined gene therapy
@en
Internal ribosome entry site-based vectors for combined gene therapy
@nl
type
label
Internal ribosome entry site-based vectors for combined gene therapy
@ast
Internal ribosome entry site-based vectors for combined gene therapy
@en
Internal ribosome entry site-based vectors for combined gene therapy
@nl
prefLabel
Internal ribosome entry site-based vectors for combined gene therapy
@ast
Internal ribosome entry site-based vectors for combined gene therapy
@en
Internal ribosome entry site-based vectors for combined gene therapy
@nl
P2093
P2860
P356
P1476
Internal ribosome entry site-based vectors for combined gene therapy
@en
P2093
Anne-Catherine Prats
Barbara Garmy-Susini
Edith Renaud-Gabardos
Fransky Hantelys
Xavier Chaufour
P2860
P356
10.5493/WJEM.V5.I1.11
P407
P577
2015-02-20T00:00:00Z